Higher costs may justify prophylaxis in prostate and lung cancer patients with bone metastases.
D001859:Bone Neoplasms / Q000556:secondary*; D017048:Health Care Costs; D006801:Humans; D008175:Lung Neoplasms / Q000191:economics / Q000628:therapy*; D008297:Male; D011471:Prostatic Neoplasms / Q000191:economics / Q000628:therapy*